BioTek Receives LanthaScreen™ Plus Certification from Invitrogen™ for Multi-Mode Microplate Readers

BioTek Instruments Inc., announced that it was awarded the LanthaScreen™ Certified Plus designation from Invitrogen Corporation, a provider of essential life science technologies for research, production and diagnostics.

The LanthaScreen™ Certified Plus mark ensures that BioTek’s Synergy™ 4 and Synergy™ 2 multi-mode microplate readers are validated to strict standards in instrument setup and assay performance.

LanthaScreen™ technology uses time-resolved fluorescence resonance energy transfer (TR-FRET) to study multiple target classes including protein kinases, nuclear hormone receptors, as well as proteases and ubiquitinated proteins.

BioTek’s recently introduced patent-pending Synergy™ 4 Hybrid Microplate Reader is the first multi-mode reader to combine sensitive filter-based and quadruple monochromator-based fluorescence detection technology in one compact unit.

Using this Hybrid Technology™, customers can now benefit from endless flexibility and true multi-detection for an unlimited number of current and future microplate-based assays.

In addition, Synergy 4 includes Fluorescence Intensity, Luminescence, Fluorescence Polarization, Time-Resolved Fluorescence, and UV-Visible Absorbance.

The Synergy 2 Multi-Mode Microplate Reader is a modular reader incorporating detection modes for Fluorescence Intensity, Fluorescence Polarization, Time Resolved Fluorescence, Luminescence and UV-visible Absorbance.

Synergy 2 uses a combination of monochromator, filters, and dichroic mirrors and three broad-spectrum light sources for optimal illumination that provide the best possible level of performance in all detection modes without performance degradation.